sPLA2 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for sPLA2 inhibitor (unspecified), covering 2009-10-09 to 2009-10-09. Get the full timeline:
Most recent: Clinical Trial Update: sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial [Phase 2]